Family Capital Trust Co reduced its stake in Danaher Co. (NYSE:DHR) by 3.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 30,742 shares of the conglomerate’s stock after selling 1,103 shares during the period. Danaher accounts for 1.4% of Family Capital Trust Co’s holdings, making the stock its 24th biggest holding. Family Capital Trust Co’s holdings in Danaher were worth $3,340,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Mount Yale Investment Advisors LLC bought a new stake in shares of Danaher in the first quarter valued at approximately $103,000. IMS Capital Management bought a new stake in shares of Danaher in the second quarter valued at approximately $107,000. BerganKDV Wealth Management LLC bought a new stake in shares of Danaher in the second quarter valued at approximately $111,000. Fort L.P. bought a new stake in shares of Danaher in the second quarter valued at approximately $119,000. Finally, Braun Bostich & Associates Inc. raised its position in shares of Danaher by 506.4% in the second quarter. Braun Bostich & Associates Inc. now owns 1,225 shares of the conglomerate’s stock valued at $121,000 after purchasing an additional 1,023 shares during the period. 76.80% of the stock is owned by hedge funds and other institutional investors.
A number of analysts recently weighed in on the stock. Robert W. Baird decreased their target price on shares of Danaher from $116.00 to $114.00 and set an “outperform” rating on the stock in a report on Friday, October 19th. Zacks Investment Research lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Friday, October 12th. Morgan Stanley increased their price target on shares of Danaher from $122.00 to $126.00 and gave the stock an “overweight” rating in a report on Wednesday, October 10th. Royal Bank of Canada increased their price target on shares of Danaher to $107.00 and gave the stock a “positive” rating in a report on Thursday, July 19th. They noted that the move was a valuation call. Finally, Bank of America set a $113.00 price target on shares of Danaher and gave the stock a “buy” rating in a report on Thursday, July 19th. One analyst has rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $112.14.
NYSE DHR traded down $0.36 during trading on Friday, hitting $104.39. The company had a trading volume of 2,608,564 shares, compared to its average volume of 3,078,206. The company has a current ratio of 1.53, a quick ratio of 1.08 and a debt-to-equity ratio of 0.38. Danaher Co. has a one year low of $91.65 and a one year high of $110.13. The firm has a market capitalization of $72.94 billion, a PE ratio of 25.90, a price-to-earnings-growth ratio of 2.00 and a beta of 1.04.
Danaher (NYSE:DHR) last issued its quarterly earnings results on Thursday, October 18th. The conglomerate reported $1.10 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.07 by $0.03. The company had revenue of $4.85 billion during the quarter, compared to analyst estimates of $4.80 billion. Danaher had a net margin of 14.07% and a return on equity of 11.59%. Danaher’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same period last year, the business earned $1.00 EPS. On average, sell-side analysts predict that Danaher Co. will post 4.51 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Friday, October 26th. Investors of record on Friday, September 28th were paid a $0.16 dividend. The ex-dividend date was Thursday, September 27th. This represents a $0.64 annualized dividend and a dividend yield of 0.61%. Danaher’s payout ratio is 15.88%.
In related news, CFO Daniel L. Comas sold 36,000 shares of the stock in a transaction dated Thursday, November 8th. The shares were sold at an average price of $103.88, for a total value of $3,739,680.00. Following the completion of the transaction, the chief financial officer now directly owns 124,218 shares in the company, valued at approximately $12,903,765.84. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Donald J. Ehrlich sold 10,578 shares of the firm’s stock in a transaction dated Tuesday, October 23rd. The shares were sold at an average price of $95.77, for a total transaction of $1,013,055.06. Following the sale, the director now owns 105,491 shares of the company’s stock, valued at $10,102,873.07. The disclosure for this sale can be found here. Over the last quarter, insiders sold 150,007 shares of company stock valued at $15,202,163. 11.90% of the stock is owned by company insiders.
COPYRIGHT VIOLATION NOTICE: This news story was posted by Equities Focus and is owned by of Equities Focus. If you are reading this news story on another domain, it was illegally copied and reposted in violation of US & international trademark and copyright law. The legal version of this news story can be accessed at https://www.equitiesfocus.com/2018/11/10/family-capital-trust-co-reduces-position-in-danaher-co-dhr.html.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Recommended Story: Risk Tolerance and Your Investment Decisions
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.